Comparative Pharmacology
Head-to-head clinical analysis: CHG SCRUB versus CIDA STAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHG SCRUB versus CIDA STAT.
CHG SCRUB vs CIDA-STAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts bacterial cell membranes, leading to leakage of intracellular contents and cell death. It also binds to proteins and inhibits bacterial enzymes.
CIDA-STAT is a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to increased hepatic LDL receptor expression and reduced plasma LDL cholesterol levels.
Apply 5 mL to wet skin, scrub for 2 minutes, rinse thoroughly. Use undiluted.
10 mg orally once daily
None Documented
None Documented
Approximately 2 hours (terminal); prolonged in renal impairment.
Terminal half-life: 12-15 hours; requires dose adjustment in renal impairment (CrCl <30 mL/min)
Primarily renal (90% unchanged); <5% biliary/fecal.
Renal: 30% unchanged; Biliary/fecal: 60% as metabolites; 10% other
Category C
Category C
Antiseptic
Antiseptic